Form 4 for RMD ResMed|
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-15 · accession 0001127602-22-025844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-16 | 2022-11-15 | RMD | BLAISE LUCILE | Pres, Sleep, RC Business | S - Sale+OE | $225.18 | -169 | 7,335 | -2% | -$38.1K | |
| 2022-11-16 | 2022-11-15 | RMD | BLAISE LUCILE | Pres, Sleep, RC Business | M - OptEx | $225.18 | +516 | 7,504 | +7% | +$116.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-15 | S | D | 169 | $225.18 | 7,335 | D | — | — | (F2) Includes 72.515 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan. |
| 2 | Common | ResMed Common Stock | 2022-11-15 | M | A | 516 | $225.18 | 7,504 | D | — | — |